ALKERMES PLC's ticker is ALKS and the CUSIP is G01767105. A total of 194 filers reported holding ALKERMES PLC in Q4 2013. The put-call ratio across all filers is 1.34 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $74,199 | -68.3% | 2,649 | -64.5% | 0.00% | -75.0% |
Q2 2023 | $233,874 | +162312.5% | 7,472 | +46.6% | 0.01% | +60.0% |
Q1 2023 | $144 | +166.7% | 5,097 | +148.9% | 0.01% | +150.0% |
Q4 2022 | $54 | -100.0% | 2,048 | -89.6% | 0.00% | -71.4% |
Q3 2022 | $440,000 | +16.7% | 19,676 | +55.6% | 0.01% | -12.5% |
Q2 2022 | $377,000 | +1008.8% | 12,646 | +873.5% | 0.01% | – |
Q1 2022 | $34,000 | -91.0% | 1,299 | -92.0% | 0.00% | -100.0% |
Q4 2021 | $378,000 | +94.8% | 16,256 | +157.7% | 0.01% | +40.0% |
Q3 2021 | $194,000 | +18.3% | 6,309 | -5.8% | 0.01% | +25.0% |
Q2 2021 | $164,000 | +530.8% | 6,696 | +383.8% | 0.00% | – |
Q1 2021 | $26,000 | -93.9% | 1,384 | -93.6% | 0.00% | -100.0% |
Q4 2020 | $429,000 | +304.7% | 21,520 | +236.8% | 0.01% | +1200.0% |
Q3 2020 | $106,000 | +21.8% | 6,389 | +43.3% | 0.00% | -75.0% |
Q2 2020 | $87,000 | +2800.0% | 4,457 | +2794.2% | 0.00% | – |
Q4 2019 | $3,000 | -75.0% | 154 | -73.9% | 0.00% | -100.0% |
Q3 2019 | $12,000 | +9.1% | 591 | +20.6% | 0.00% | 0.0% |
Q2 2019 | $11,000 | +266.7% | 490 | +490.4% | 0.00% | – |
Q1 2019 | $3,000 | -97.6% | 83 | -97.1% | 0.00% | -100.0% |
Q3 2018 | $123,000 | +127.8% | 2,908 | +123.7% | 0.01% | +200.0% |
Q2 2018 | $54,000 | -90.5% | 1,300 | -86.8% | 0.00% | -93.9% |
Q1 2018 | $571,000 | +18933.3% | 9,860 | +15306.2% | 0.05% | – |
Q3 2017 | $3,000 | -81.2% | 64 | -77.5% | 0.00% | -100.0% |
Q2 2017 | $16,000 | +220.0% | 284 | +234.1% | 0.00% | +100.0% |
Q4 2016 | $5,000 | +25.0% | 85 | +1.2% | 0.00% | – |
Q3 2016 | $4,000 | -84.0% | 84 | -88.5% | 0.00% | -100.0% |
Q1 2016 | $25,000 | +733.3% | 733 | +1565.9% | 0.00% | – |
Q3 2015 | $3,000 | -98.4% | 44 | -98.5% | 0.00% | -100.0% |
Q2 2015 | $186,000 | -8.4% | 2,896 | -13.0% | 0.02% | -36.0% |
Q1 2015 | $203,000 | +2.0% | 3,327 | -1.9% | 0.02% | +31.6% |
Q4 2014 | $199,000 | +804.5% | 3,390 | +668.7% | 0.02% | +533.3% |
Q2 2014 | $22,000 | -8.3% | 441 | -19.7% | 0.00% | 0.0% |
Q1 2014 | $24,000 | -68.0% | 549 | -70.1% | 0.00% | -76.9% |
Q4 2013 | $75,000 | +2400.0% | 1,837 | +1737.0% | 0.01% | – |
Q3 2013 | $3,000 | – | 100 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Woodford Investment Management Ltd | 2,639,676 | $96,322,000 | 7.78% |
Meditor Group Ltd | 892,400 | $32,564,000 | 6.11% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 233,000 | $8,502,000 | 3.14% |
Tamarack Advisers, LP | 140,000 | $5,109,000 | 2.03% |
Asymmetry Capital Management, L.P. | 27,673 | $1,010,000 | 1.69% |
First Light Asset Management, LLC | 211,164 | $7,705,000 | 1.00% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 304,992 | $11,129,000 | 0.85% |
Nicollet Investment Management, Inc. | 28,020 | $1,022,000 | 0.67% |
PRIMECAP MANAGEMENT CO/CA/ | 23,263,530 | $848,886,000 | 0.62% |
Rhenman & Partners Asset Management AB | 120,399 | $4,393,000 | 0.51% |